E
Entheon Biomedical Corp
OTC:ENTBF
Entheon Biomedical Corp
OTC:ENTBF
Price:
0.079
USD
Market Cap:
$699.9k
Income Statement
Earnings Waterfall
Entheon Biomedical Corp
Entheon Biomedical Corp
Income Statement
Entheon Biomedical Corp
Entheon Biomedical Corp
Currency: CAD
| Jun-2020 | Sep-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+147%
|
0
+486%
|
0
+41%
|
0
+34%
|
0
+164%
|
0
+75%
|
0
+59%
|
1
+79%
|
0
-13%
|
0
-47%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-5%
|
0
+55%
|
0
+544%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(2)
|
(5)
|
(7)
|
(9)
|
(9)
|
(8)
|
(7)
|
(6)
|
(4)
|
(2)
|
(1)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(1)
|
(4)
|
(5)
|
(7)
|
(7)
|
(6)
|
(5)
|
(4)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Research & Development |
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
-54%
|
(2)
-533%
|
(5)
-203%
|
(7)
-41%
|
(9)
-23%
|
(9)
-5%
|
(8)
+14%
|
(7)
+8%
|
(6)
+12%
|
(4)
+43%
|
(2)
+48%
|
(1)
+73%
|
0
N/A
|
(0)
N/A
|
(0)
-25%
|
(0)
+10%
|
(0)
+8%
|
(0)
-3%
|
(0)
-21%
|
(0)
+8%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
-68%
|
(4)
-1 773%
|
(7)
-69%
|
(10)
-32%
|
(11)
-16%
|
(9)
+22%
|
(8)
+11%
|
(7)
+15%
|
(5)
+32%
|
(2)
+55%
|
(0)
+86%
|
1
N/A
|
0
-65%
|
(0)
N/A
|
(0)
-25%
|
(0)
+10%
|
(0)
+9%
|
(0)
-3%
|
(0)
-22%
|
(0)
+7%
|
|
| Net Income | ||||||||||||||||||||||
| Income from Continuing Operations |
(0)
|
(0)
|
(4)
|
(7)
|
(10)
|
(11)
|
(9)
|
(8)
|
(7)
|
(5)
|
(2)
|
(0)
|
1
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
-68%
|
(4)
-1 773%
|
(7)
-69%
|
(10)
-32%
|
(11)
-16%
|
(9)
+22%
|
(8)
+11%
|
(7)
+15%
|
(5)
+32%
|
(9)
-87%
|
(7)
+21%
|
(6)
+17%
|
(6)
-10%
|
(0)
+95%
|
(0)
-25%
|
(0)
+10%
|
(0)
+9%
|
(0)
-3%
|
(0)
-22%
|
(0)
+7%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.01
N/A
|
-0.48
-4 700%
|
-0.15
+69%
|
-0.18
-20%
|
-0.2
-11%
|
-1.64
-720%
|
-0.14
+91%
|
-0.12
+14%
|
-0.08
+33%
|
-1.44
-1 700%
|
-1.14
+21%
|
-0.94
+18%
|
-1.04
-11%
|
-0.05
+95%
|
-0.06
-20%
|
-0.05
+17%
|
-0.05
N/A
|
-0.04
+20%
|
-0.04
N/A
|
-0.03
+25%
|
|
Switch to:
Switch to:
See Also
Discover More
